In the Shadow of the Dragon

This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case B looks at Sandoz once it has become independent. The hard work of figuring out the best way to spin off is done, a new strategy created, and so...

The Sandoz leadership team faced an important decision as it broke away from Novartis and became a public company. Should Sandoz retain the global geographical coverage it had had in its many years as part of Novartis? Or should it focus on fewer ...

This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case A follows Richard Saynor's (CEO, Sandoz) ruminations as he builds the company strategy in preparation for the board's approval of Sandoz as a st...

This book is a vindication of Europe. It challenges the view of Europe as a tired, overregulated continent, arguing instead that Europe has emerged from decades of crisis—financial turmoil, Brexit, COVID-19, war in Ukraine—as a resilient, reformed...

Purpose Jean Boddewyn’s (1929–2022) work in international business political behavior launched a stream of research at the intersection of international business (IB) and strategic management that is now referred to as international nonmarket str...

When policymakers start using internet slang to describe the economy, it is a sign something is not right. The word neijuan was once used by Chinese students to depict burnout from seemingly pointless competition. Now it is showing up in policy la...

The recent and rapid ascent of China into today's scientific powerhouse is increasingly debated in circles of economic politics and policy making. Yet, we still know relatively little how such rise has materialized in terms of Chinese scientists' ...